AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.500
-0.050 (-1.41%)
At close: Dec 5, 2025, 4:00 PM EST
3.490
-0.010 (-0.29%)
After-hours: Dec 5, 2025, 6:32 PM EST

AVITA Medical Stock Forecast

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for AVITA Medical stock ranges from a low of $4.00 to a high of $21. The average analyst price target of $11.75 forecasts a 235.71% increase in the stock price over the next year.

Price Target: $11.75 (+235.71%)
Analyst Consensus: Buy
Target Low Average Median High
Price $4.00 $11.75 $14 $21
Change +14.29% +235.71% +300.00% +500.00%

Analyst Ratings

The average analyst rating for AVITA Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 222222
Buy 111111
Hold 111222
Sell 000000
Strong Sell 000000
Total 444555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Hold
Upgrades
n/a
Hold Upgrades n/a n/a Nov 20, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$14
Strong Buy Maintains $14 +300.00% Nov 7, 2025
Lake Street
Lake Street
Hold
Downgrades
$8$4
Hold Downgrades $8$4 +14.29% Oct 17, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$14
Strong Buy Maintains $14 +300.00% Oct 17, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$14
Strong Buy Maintains $14 +300.00% Sep 15, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
72.68M
from 64.25M
Increased by 13.12%
Revenue Next Year
92.71M
from 72.68M
Increased by 27.56%
EPS This Year
-1.51
from -2.39
EPS Next Year
-0.84
from -1.51
Fiscal Year FY 2021 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Jun 30, 2021 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
29.23M33.03M34.42M50.14M64.25M72.68M92.71M
Revenue Growth
104.95%12.98%4.23%45.68%28.14%13.12%27.56%
EPS
-1.17-1.03-1.07-1.40-2.39-1.51-0.84
EPS Growth
-------
Forward PE
-------
No. Analysts
-----88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High 76.4M 124.4M
Avg 72.7M 92.7M
Low 68.6M 76.4M

Revenue Growth

Revenue Growth 202520262027202820292030
High
19.0%
71.1%
Avg
13.1%
27.6%
Low
6.8%
5.2%

EPS Forecast

EPS 202520262027202820292030
High -0.38 -0.18
Avg -1.51 -0.84
Low -1.76 -1.50

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.